What once seemed like a dream-to think that the body had the ability to self-regenerate in the face of a health problem-is now a reality thanks to cellular regenerative medicine. This discipline has developed treatments to combat autoimmune diseases, and also to address neurological events such as stroke, failure of vital organs and even reverse processes associated with aging.

Thes advances have generated innovative medical procedures with cutting-edge cells, among which the safest and most effective ones stand out: the Japanese Dezawa MUSE cells.

(Multilineage-differentiating Stress-Enduring cells), discovered by Dr. Mari Dezawa. Today, these therapies can already be applied in our country through Neorgana clinics.

“Neorgana was born from a conviction. More than a decade ago, an experience transformed my life: I saw how regenerative medicine saved my father from being disabled after a serious accident. That moment showed me first-hand the true power of these therapies and the need for them not to be limited to a few. A project had to be created that united science, innovation and humanity.

This is how Neorgana was born, with the mission of bringing cell therapy closer – and today in particular the dezawa MUSE Cells-to more people. One of our main objectives is for these therapies to be applied in hospitals as the first line of response to strokes, heart attacks and accidents, since we are convinced that this would change many prognoses as we are already doing in our clinics” explains Tatiana Holder-Novelo, CRO and co-founder, together with her husband, Omar Novelo Medina, CEO of Neorgana.

According to Holder-Novelo, for years so-called mesenchymal stem cells dominated the regenerative medicine scene. Though, this field today makes quantum leaps, and the most critically important in recent years is the Dezawa MUSE Cells.within regenerative medicine: they are tiny natural biological messengers, they carry regenerative, immunomodulatory and anti-inflammatory signals. In this way, they enhance and amplify the action of the MUSE Cells.

preparing the environment so that regeneration occurs more efficiently and lastingly.

Unlike exosomes derived from mesenchymal stem cells-whose effect is limited and highly variable, as they depend on the quality of the donor cells-MUSE Exosomes

They come from safe pluripotent cells. This means that they load much more complete and consistent signals, capable of activating deeper and more stable repair processes. They can be used as a complement to MUSE Cells

as well as its own protocols for inflammation, chronic pain, functional recovery and longevity, with notable clinical results.Dr. Omar Novelo Baeza, Medical Director of Neorgana, explains:
“We have seen clinical results that are rarely achieved in medicine. With the Dezawa MUSE Cells

Neorgana Announces Exclusive Rights to Revolutionary Muse Cell Technology in Spain and Portugal

Neorgana, a Spanish biotechnology company, has announced an exclusive agreement with MCI (Muse Cell Innovations) to bring groundbreaking Muse Cell technology to Spain and Portugal. This technology, developed by Dr. Hidenobu Dezawa, offers the potential to regenerate organs and tissues, marking a significant advancement in regenerative medicine.

Muse Cells, derived from a patient’s own bone marrow, possess the unique ability to differentiate into various cell types, effectively repairing damaged tissues and organs. Unlike stem cells, Muse Cells do not form tumors and have demonstrated remarkable regenerative capabilities in preclinical and clinical studies.

the agreement grants Neorgana the exclusive rights to develop, manufacture, and commercialize Muse Cell-based therapies in spain and Portugal, covering a wide range of potential applications including osteoarthritis, diabetes, heart disease, and neurodegenerative disorders.

“For Neorgana it is a true honor to collaborate closely with MCI, always aligned with thier scientific authority, sharing their vision and being an active part of this legacy that is transforming regenerative medicine,” stated a company representative.

Dr. Dezawa’s Muse Cells “mark the beginning of a true renaissance in medicine. For the first time we have a tool capable of regenerating organs and tissues in a real, safe and effective way. They fulfill the original promise of regenerative medicine: to repair what seemed irreparable and restore health and hope to patients. In addition, they show us the way to systemic rejuvenation, which prolongs vitality and prevents disease.” Neorgana is committed to building this future,working in close collaboration with MCI and Dr. Dezawa.